ZA881081B - Virus antigen,method for its preparation and its use for diagnostic and therapeutic purposes(vaccines) - Google Patents
Virus antigen,method for its preparation and its use for diagnostic and therapeutic purposes(vaccines)Info
- Publication number
- ZA881081B ZA881081B ZA881081A ZA881081A ZA881081B ZA 881081 B ZA881081 B ZA 881081B ZA 881081 A ZA881081 A ZA 881081A ZA 881081 A ZA881081 A ZA 881081A ZA 881081 B ZA881081 B ZA 881081B
- Authority
- ZA
- South Africa
- Prior art keywords
- vaccines
- diagnostic
- preparation
- therapeutic purposes
- virus antigen
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
- C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873705512 DE3705512A1 (en) | 1987-02-20 | 1987-02-20 | Virus antigen, process for obtaining it and use in diagnosis and therapy (vaccine) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA881081B true ZA881081B (en) | 1988-08-11 |
Family
ID=6321438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA881081A ZA881081B (en) | 1987-02-20 | 1988-02-16 | Virus antigen,method for its preparation and its use for diagnostic and therapeutic purposes(vaccines) |
Country Status (3)
| Country | Link |
|---|---|
| DE (1) | DE3705512A1 (en) |
| SU (1) | SU1711676A3 (en) |
| ZA (1) | ZA881081B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD34Z5 (en) * | 2008-05-20 | 2010-01-31 | Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова | Method for diagnosing the viral hepatitis B to babies of up to one year |
| MD1166Z (en) * | 2017-01-19 | 2018-02-28 | Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова | Method for testing donor blood for viral hepatitis B markers |
-
1987
- 1987-02-20 DE DE19873705512 patent/DE3705512A1/en active Granted
-
1988
- 1988-02-16 ZA ZA881081A patent/ZA881081B/en unknown
-
1989
- 1989-10-19 SU SU894356796A patent/SU1711676A3/en active
Also Published As
| Publication number | Publication date |
|---|---|
| SU1711676A3 (en) | 1992-02-07 |
| DE3705512C2 (en) | 1991-10-02 |
| DE3705512A1 (en) | 1988-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK102595A (en) | Hepatitis delta diagnostics and vaccines, their preparation and use | |
| ZA90171B (en) | Treatment methods and vaccines for stimulating an immune response | |
| EP0109942A3 (en) | Immunogenic protein or peptide complex, method of producing said complex and the use thereof as an immune stimulant and as a vaccine | |
| IL68749A (en) | Modified antigens,their preparation and vaccines containing them | |
| EP0283505A4 (en) | Vaccine and method of preparation. | |
| AU1347688A (en) | Viral antigen, process for its production, and application in diagnosis and therapy (vaccine) | |
| NL189207C (en) | FLAVIVIRUS ANTIGEN, PROCESS FOR THE PREPARATION THEREOF, INTERMEDIATES AND PROCESS FOR PREPARING A VACCINE AGAINST JAPANESE ENCEPHALITIS. | |
| AU1631188A (en) | Newcastle disease virus vaccine and method for the application thereof | |
| NZ221227A (en) | Hiv envelope proteins, antigenic fragments vaccines; and diagnostic methods | |
| DE3160264D1 (en) | Process for isolating viral glycoproteic antigens, and its use in the preparation of vaccines | |
| HUT65448A (en) | New immunogenic polypeptides, vaccines containing them and method for preparation and use of them | |
| ZA904565B (en) | Peptides and antibodies derived therefrom for the diagnosis of therapy for and vaccination against htlv-1 infection | |
| IL85088A (en) | Anti-malarial peptides,their copolymers and vaccines comprising them | |
| EP0467972A4 (en) | Rickettsial antigens for vaccination and diagnosis | |
| AU632545B2 (en) | Hog cholera virus vaccine and diagnostic | |
| DK134990D0 (en) | PREPARATION FOR DENTAL TREATMENT AND PROCEDURE FOR PREPARING THEREOF | |
| IL71953A (en) | Malaria associated antigen,process for preparation thereof and vaccine comprising it | |
| ZA881081B (en) | Virus antigen,method for its preparation and its use for diagnostic and therapeutic purposes(vaccines) | |
| IL81920A (en) | Vaccines comprising an antigen and interferon-ypsilon and their preparation | |
| DE3666666D1 (en) | Early-summer meningo-encephalitis virus (fsme-virus) vaccine, and method of producing the same | |
| JPS6471488A (en) | Preparation of human immunodeficient virus type i antigen, and its use as diagnostic and curing agents | |
| EP0240366A3 (en) | Perhydrothiazepine and perhydroazepine derivatives, their preparation and their therapeutic use | |
| IL81650A0 (en) | Purified human angiogenic factor,method for its preparation and pharmaceutical preparations | |
| GB2200638B (en) | Babesia divergens antigen and vaccine | |
| GR3031499T3 (en) | Hog cholera virus vaccine and diagnostic. |